Procyrion

Executive Summary

Procyrion is a private medical device company based in Houston, founded in 2005, that is developing innovative circulatory support solutions for heart failure patients. The company's lead product, Aortix™, is a catheter-deployed percutaneous mechanical circulatory support (pMCS) device designed to reduce cardiac workload and increase renal perfusion. Aortix specifically targets the large and growing unmet need in patients with acute decompensated heart failure (ADHF) and cardiorenal syndrome, a condition where heart failure exacerbates kidney dysfunction. The device offers a less invasive alternative to traditional surgical options, potentially improving outcomes and reducing hospital stays.

Upcoming Catalysts (preview)

• Q3 2026Pivotal Trial Data Readout for Aortix70% success
• H2 2026FDA Approval of Aortix60% success
• Q4 2026Series C Financing Round80% success